Liraglutide Promotes Osteoblastic Differentiation in MC3T3-E1 Cells by ERK5 Pathway

Figure 1

Effects of liraglutide on the viability of MC3T3-E1 cells. The cells were treated with liraglutide at different concentrations for 24, 48, and, 72 h, and the cell viability was assessed by using CCK-8 assay.  < 0.01 compared with 0 nM,  < 0.01 compared with 10 nM, and  < 0.01 compared with 100 nM.